These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22256965)

  • 21. Metabolic effects of a growth hormone-releasing factor in patients with HIV.
    Falutz J; Allas S; Blot K; Potvin D; Kotler D; Somero M; Berger D; Brown S; Richmond G; Fessel J; Turner R; Grinspoon S
    N Engl J Med; 2007 Dec; 357(23):2359-70. PubMed ID: 18057338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum adipokine zinc α2-glycoprotein and lipolysis in cachectic and noncachectic heart failure patients: relationship with neurohormonal and inflammatory biomarkers.
    Tedeschi S; Pilotti E; Parenti E; Vicini V; Coghi P; Montanari A; Regolisti G; Fiaccadori E; Cabassi A
    Metabolism; 2012 Jan; 61(1):37-42. PubMed ID: 21696792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of rosiglitazone on flow-mediated dilation and other markers of cardiovascular risk in HIV-infected patients with lipoatrophy.
    Kovacic JC; Martin A; Carey D; Wand H; Mallon PW; Feneley MP; Emery S; Cooper DA; Carr A;
    Antivir Ther; 2005; 10(1):135-43. PubMed ID: 15751771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The basis and management of metabolic abnormalities associated with cardiovascular risk in human immunodeficiency virus infection and its treatment.
    Crook M
    Ann Clin Biochem; 2007 May; 44(Pt 3):219-31. PubMed ID: 17456292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumour necrosis factor alpha in fat redistribution syndromes associated with combination antiretroviral therapy in HIV-1-infected patients: potential role in subcutaneous adipocyte apoptosis.
    Domingo P; Vidal F; Domingo JC; Veloso S; Sambeat MA; Torres F; Sirvent JJ; Vendrell J; Matias-Guiu X; Richart C;
    Eur J Clin Invest; 2005 Dec; 35(12):771-80. PubMed ID: 16313254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease.
    Guaraldi G; Ventura P; Garlassi E; Orlando G; Squillace N; Nardini G; Stentarelli C; Zona S; Marchini S; Moriondo V; Tebas P
    HIV Med; 2009 Jan; 10(1):28-34. PubMed ID: 19125962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels.
    Lihn AS; Richelsen B; Pedersen SB; Haugaard SB; Rathje GS; Madsbad S; Andersen O
    Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1072-80. PubMed ID: 12876073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor necrosis factor alpha is associated with insulin-mediated suppression of free fatty acids and net lipid oxidation in HIV-infected patients with lipodystrophy.
    Haugaard SB; Andersen O; Pedersen SB; Dela F; Fenger M; Richelsen B; Madsbad S; Iversen J
    Metabolism; 2006 Feb; 55(2):175-82. PubMed ID: 16423623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased mitochondrial DNA content in peripheral blood lymphocytes from HIV-infected patients with lipodystrophy.
    Cossarizza A; Riva A; Pinti M; Ammannato S; Fedeli P; Mussini C; Esposito R; Galli M
    Antivir Ther; 2003 Aug; 8(4):315-21. PubMed ID: 14518701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitors.
    Martínez E; Domingo P; Ribera E; Milinkovic A; Arroyo JA; Conget I; Pérez-Cuevas JB; Casamitjana R; de Lazzari E; Bianchi L; Montserrat E; Roca M; Burgos R; Arnaiz JA; Gatell JM
    Antivir Ther; 2003 Oct; 8(5):403-10. PubMed ID: 14640387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between HLA-B*4001 and lipodystrophy among HIV-infected patients from Thailand who received a stavudine-containing antiretroviral regimen.
    Wangsomboonsiri W; Mahasirimongkol S; Chantarangsu S; Kiertiburanakul S; Charoenyingwattana A; Komindr S; Thongnak C; Mushiroda T; Nakamura Y; Chantratita W; Sungkanuparph S
    Clin Infect Dis; 2010 Feb; 50(4):597-604. PubMed ID: 20073992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men--a randomized, placebo-controlled study.
    Mallon PW; Miller J; Kovacic JC; Kent-Hughes J; Norris R; Samaras K; Feneley MP; Cooper DA; Carr A
    AIDS; 2006 Apr; 20(7):1003-10. PubMed ID: 16603852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.
    Hadigan C; Meigs JB; Corcoran C; Rietschel P; Piecuch S; Basgoz N; Davis B; Sax P; Stanley T; Wilson PW; D'Agostino RB; Grinspoon S
    Clin Infect Dis; 2001 Jan; 32(1):130-9. PubMed ID: 11118392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum zinc-alpha2-glycoprotein correlates with adiposity, triglycerides, and the key components of the metabolic syndrome in Chinese subjects.
    Yeung DC; Lam KS; Wang Y; Tso AW; Xu A
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2531-6. PubMed ID: 19351730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV/antiretroviral therapy-related lipodystrophy syndrome (HALS) is associated with higher RBP4 and lower omentin in plasma.
    Peraire J; López-Dupla M; Alba V; Beltrán-Debón R; Martinez E; Domingo P; Asensi V; Leal M; Viladés C; Inza MI; Escoté X; Arnedo M; Mateo G; Valle-Garay E; Ferrando-Martinez S; Veloso S; Vendrell J; Gatell JM; Vidal F;
    Clin Microbiol Infect; 2015 Jul; 21(7):711.e1-8. PubMed ID: 25882366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No relationship between TNF-α genetic variants and combination antiretroviral therapy-related lipodystrophy syndrome in HIV type 1-infected patients: a case-control study and a meta-analysis.
    Veloso S; Olona M; Peraire J; Viladés C; Pardo P; Domingo P; Asensi V; Broch M; Aguilar C; López-Dupla M; Aragonés G; Garcia-Pardo G; Sirvent JJ; Vendrell J; Richart C; Vidal F;
    AIDS Res Hum Retroviruses; 2011 Feb; 27(2):143-52. PubMed ID: 20854131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipodystrophy and insulin resistance in combination antiretroviral treated HIV-1-infected patients: implication of resistin.
    Escoté X; Miranda M; Veloso S; Domingo P; Alonso-Villaverde C; Peraire J; Viladés C; Alba V; Olona M; Castro A; López-Dupla M; Sirvent JJ; Vicente V; Vendrell J; Richart C; Vidal F;
    J Acquir Immune Defic Syndr; 2011 May; 57(1):16-23. PubMed ID: 21317795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients.
    Domingo P; Lamarca MK; Gallego-Escuredo JM; Torres F; Domingo JC; Villarroya J; Gutierrez Mdel M; Mateo MG; Vidal F; Villarroya F; Giralt M
    J Antimicrob Chemother; 2015; 70(6):1825-32. PubMed ID: 25700720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms in adiponectin receptor genes are associated with lipodystrophy-related phenotypes in HIV-infected patients receiving antiretroviral therapy.
    Castilhos JK; Sprinz E; Lazzaretti RK; Kuhmmer R; Mattevi VS
    HIV Med; 2015 Sep; 16(8):494-501. PubMed ID: 26111083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy.
    Hearps AC; Maisa A; Cheng WJ; Angelovich TA; Lichtfuss GF; Palmer CS; Landay AL; Jaworowski A; Crowe SM
    AIDS; 2012 Apr; 26(7):843-53. PubMed ID: 22313961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.